Some people, such as those with diabetes, are unable to produce or use insulin or glucagon effectively. In this case, healthcare providers prescribe insulin and glucagon as medications that people ...

The FDA approved Gvoke, a ready-to-use glucagon product, for the treatment of severe hypoglycemia in 2019. The format is potentially more convenient than traditional glucagon kits from the likes ...

Glucagon—like insulin ... Discovery Institute has found potential new ways to make better medicines using pre-clinical models ...

Through this important partnership, we can save lives by ensuring individuals with diabetes who are treated with insulin have access to glucagon, preferably a ready-to-use formulation, so they can ...

Glucagon prescriptions for severe hypoglycemia ... This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

ACCP is a non-profit association providing accredited Continuing Education, publications and career-enhancing opportunities to clinical pharmacology healthcare professionals. We sell different ...

Feb. 5, 2025 /PRNewswire/ -- The American College of Clinical Pharmacology ® (ACCP) published a recent Position Paper entitled "Ensuring the Appropriate Use of Glucagon-Like Peptide-1 Receptor ...